Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Premera Blue Cross	7.01.594 Percutaneous Revascularization Procedures for LowerPayerPolicy · PREMERA-7-01-594-PERCUTANEOUS-REVASCULARIZATION-PROCEDURES-FOR-LOWER-1CE011D4FE	New policy
Aug 2, 2026	Premera Blue Cross	7.01.563 Ablative Treatments for Occipital Neuralgia, ChronicPayerPolicy · PREMERA-7-01-563-ABLATIVE-TREATMENTS-FOR-OCCIPITAL-NEURALGIA-CHRONIC-9BE070F1FA	New policy
Aug 2, 2026	Premera Blue Cross	7.01.175 Temporarily Implanted Nitinol Device (iTind) for BenignPayerPolicy · PREMERA-7-01-175-TEMPORARILY-IMPLANTED-NITINOL-DEVICE-ITIND-FOR-BENI-5F79A1B5CF	New policy
Aug 2, 2026	Premera Blue Cross	7.01.144 Patient-Specific Instrumentation (e.g., Cutting GuidesPayerPolicy · PREMERA-7-01-144-PATIENT-SPECIFIC-INSTRUMENTATION-E-G-CUTTING-GUIDES-BC19C0FC06	New policy
Aug 2, 2026	Premera Blue Cross	5.01.653 Miscellaneous Intravitreal DrugsPayerPolicy · PREMERA-5-01-653-MISCELLANEOUS-INTRAVITREAL-DRUGS-9E8DD86436	New policy
Aug 2, 2026	Premera Blue Cross	5.01.643 Prescription Digital Therapeutics for Substance UsePayerPolicy · PREMERA-5-01-643-PRESCRIPTION-DIGITAL-THERAPEUTICS-FOR-SUBSTANCE-USE-9DB57EA556	New policy
Aug 2, 2026	Premera Blue Cross	5.01.659 AntipsychoticsPayerPolicy · PREMERA-5-01-659-ANTIPSYCHOTICS-09B1CF94BD	New policy
Aug 2, 2026	Premera Blue Cross	5.01.588 Pharmacologic Prevention and Treatment of HIV/AIDSPayerPolicy · PREMERA-5-01-588-PHARMACOLOGIC-PREVENTION-AND-TREATMENT-OF-HIV-AIDS-E6501E22FB	New policy
Aug 2, 2026	Premera Blue Cross	2.04.119 Multibiomarker Disease Activity Blood Test for RheumatoidPayerPolicy · PREMERA-2-04-119-MULTIBIOMARKER-DISEASE-ACTIVITY-BLOOD-TEST-FOR-RHEU-93E163EC52	New policy
Aug 2, 2026	Premera Blue Cross	1.01.537 Low Intensity Pulsed Ultrasound Fracture Healing DevicePayerPolicy · PREMERA-1-01-537-LOW-INTENSITY-PULSED-ULTRASOUND-FRACTURE-HEALING-DE-13378D27EE	New policy
Aug 2, 2026	Premera Blue Cross	1.01.27 Electrical and Electromagnetic Stimulation for the TreatmentPayerPolicy · PREMERA-1-01-27-ELECTRICAL-AND-ELECTROMAGNETIC-STIMULATION-FOR-THE-T-8620002D93	New policy
Aug 2, 2026	Premera Blue Cross	7.01.607 Autografts and Allografts in the Treatment of FocalPayerPolicy · PREMERA-7-01-607-AUTOGRAFTS-AND-ALLOGRAFTS-IN-THE-TREATMENT-OF-FOCAL-136A219D3B	New policy
Aug 2, 2026	Premera Blue Cross	7.01.174 Stationary Ultrasonic Diathermy DevicesPayerPolicy · PREMERA-7-01-174-STATIONARY-ULTRASONIC-DIATHERMY-DEVICES-E04A4BEB73	New policy
Aug 2, 2026	Premera Blue Cross	7.01.171 Remote Electrical Neuromodulation for MigrainesPayerPolicy · PREMERA-7-01-171-REMOTE-ELECTRICAL-NEUROMODULATION-FOR-MIGRAINES-9B69B88149	New policy
Aug 2, 2026	Premera Blue Cross	5.01.636 Chronic Hepatitis B Antiviral TherapyPayerPolicy · PREMERA-5-01-636-CHRONIC-HEPATITIS-B-ANTIVIRAL-THERAPY-1B3023B1BE	New policy
Aug 2, 2026	Premera Blue Cross	5.01.611 Pharmacologic Treatment of Urea Cycle DisordersPayerPolicy · PREMERA-5-01-611-PHARMACOLOGIC-TREATMENT-OF-UREA-CYCLE-DISORDERS-7D75A5CC1D	New policy
Aug 2, 2026	Premera Blue Cross	5.01.571 C3 and C5 Complement InhibitorsPayerPolicy · PREMERA-5-01-571-C3-AND-C5-COMPLEMENT-INHIBITORS-6CBC314B9C	New policy
Aug 2, 2026	Premera Blue Cross	5.01.527 Ampyra (Dalfampridine)PayerPolicy · PREMERA-5-01-527-AMPYRA-DALFAMPRIDINE-627E21CF94	New policy
Aug 2, 2026	Premera Blue Cross	2.02.508 Percutaneous Coronary Intervention, Angioplasty, NonPayerPolicy · PREMERA-2-02-508-PERCUTANEOUS-CORONARY-INTERVENTION-ANGIOPLASTY-NON-A791DDC294	New policy
Aug 2, 2026	Premera Blue Cross	2.01.526 Transcranial Magnetic Stimulation as a Treatment ofPayerPolicy · PREMERA-2-01-526-TRANSCRANIAL-MAGNETIC-STIMULATION-AS-A-TREATMENT-OF-1988607438	New policy
Aug 2, 2026	Premera Blue Cross	1.04.502 Myoelectric Prosthetic and Orthotic Components for thePayerPolicy · PREMERA-1-04-502-MYOELECTRIC-PROSTHETIC-AND-ORTHOTIC-COMPONENTS-FOR-E55BF3F03A	New policy
Aug 2, 2026	Premera Blue Cross	5.01.559 IL-5 InhibitorsPayerPolicy · PREMERA-5-01-559-IL-5-INHIBITORS-7AB29AF42D	New policy
Aug 2, 2026	Premera Blue Cross	5.01.556 Rituximab: Non-oncologic and Miscellaneous UsesPayerPolicy · PREMERA-5-01-556-RITUXIMAB-NON-ONCOLOGIC-AND-MISCELLANEOUS-USES-8ED5276DE1	New policy
Aug 2, 2026	Premera Blue Cross	7.01.90 Implantable Shock Absorber for Treatment of Knee OsteoarthritiPayerPolicy · PREMERA-7-01-90-IMPLANTABLE-SHOCK-ABSORBER-FOR-TREATMENT-OF-KNEE-OST-1F5753BF7A	New policy
Aug 2, 2026	Premera Blue Cross	8.01.15 Hematopoietic Cell Transplantation for Chronic LymphocyticPayerPolicy · PREMERA-8-01-15-HEMATOPOIETIC-CELL-TRANSPLANTATION-FOR-CHRONIC-LYMPH-2F0BCC5F83	New policy
Aug 2, 2026	Premera Blue Cross	7.01.564 Pulsed Radiofrequency for the Treatment of Chronic PainPayerPolicy · PREMERA-7-01-564-PULSED-RADIOFREQUENCY-FOR-THE-TREATMENT-OF-CHRONIC-F0A4A312A9	New policy
Aug 2, 2026	Premera Blue Cross	7.01.55 Prostate Artery Embolization for Benign Prostatic HyperplasiaPayerPolicy · PREMERA-7-01-55-PROSTATE-ARTERY-EMBOLIZATION-FOR-BENIGN-PROSTATIC-HY-0B7D0FDCD7	New policy
Aug 2, 2026	Premera Blue Cross	7.01.170 Laser Interstitial Thermal Therapy for NeurologicalPayerPolicy · PREMERA-7-01-170-LASER-INTERSTITIAL-THERMAL-THERAPY-FOR-NEUROLOGICAL-053F0DB39A	New policy
Aug 2, 2026	Premera Blue Cross	7.01.163 Absorbable Nasal Implant for Treatment of Nasal ValvePayerPolicy · PREMERA-7-01-163-ABSORBABLE-NASAL-IMPLANT-FOR-TREATMENT-OF-NASAL-VAL-505CD878B4	New policy
Aug 2, 2026	Premera Blue Cross	5.01.661 Dry Eye Disease MedicationsPayerPolicy · PREMERA-5-01-661-DRY-EYE-DISEASE-MEDICATIONS-8F93E1AD09	New policy
Aug 2, 2026	Premera Blue Cross	5.01.658 (effective August 7, 2026) Denosumab ProductsPayerPolicy · PREMERA-5-01-658-EFFECTIVE-AUGUST-7-2026-DENOSUMAB-PRODUCTS-CC51B0F750	New policy
Aug 2, 2026	Premera Blue Cross	5.01.641 Pharmacologic Treatment of VitiligoPayerPolicy · PREMERA-5-01-641-PHARMACOLOGIC-TREATMENT-OF-VITILIGO-3B6C48A7AD	New policy
Aug 2, 2026	Premera Blue Cross	5.01.625 Gonadotropin Releasing Hormone (GnRH) AnalogsPayerPolicy · PREMERA-5-01-625-GONADOTROPIN-RELEASING-HORMONE-GNRH-ANALOGS-C1EE1EEBCD	New policy
Aug 2, 2026	Premera Blue Cross	5.01.548 Pharmacotherapy of Cushing's Disease and AcromegalyPayerPolicy · PREMERA-5-01-548-PHARMACOTHERAPY-OF-CUSHING-S-DISEASE-AND-ACROMEGALY-4698FD40AC	New policy
Aug 2, 2026	Premera Blue Cross	2.04.152 Maternal Serum Testing for Prediction of Adverse ObstetricPayerPolicy · PREMERA-2-04-152-MATERNAL-SERUM-TESTING-FOR-PREDICTION-OF-ADVERSE-OB-6530799858	New policy
Aug 2, 2026	Premera Blue Cross	2.02.26 Percutaneous Left Atrial Appendage Closure Devices forPayerPolicy · PREMERA-2-02-26-PERCUTANEOUS-LEFT-ATRIAL-APPENDAGE-CLOSURE-DEVICES-F-B72AEF730B	New policy
Aug 2, 2026	Premera Blue Cross	2.01.100 Dry Needling of Trigger Points for Myofascial PainPayerPolicy · PREMERA-2-01-100-DRY-NEEDLING-OF-TRIGGER-POINTS-FOR-MYOFASCIAL-PAIN-DBCFE3824C	New policy
Aug 2, 2026	Premera Blue Cross	2.01.106 Percutaneous Electrical Nerve Field Stimulation forPayerPolicy · PREMERA-2-01-106-PERCUTANEOUS-ELECTRICAL-NERVE-FIELD-STIMULATION-FOR-070AB0225B	New policy
Aug 2, 2026	Premera Blue Cross	15.01.036 Diagnosis of Idiopathic Environmental IntolerancePayerPolicy · PREMERA-15-01-036-DIAGNOSIS-OF-IDIOPATHIC-ENVIRONMENTAL-INTOLERANCE-66C66D4726	New policy
Aug 2, 2026	Premera Blue Cross	10.01.532 ASAM Criteria: Services Reviewed for Medical NecessityPayerPolicy · PREMERA-10-01-532-ASAM-CRITERIA-SERVICES-REVIEWED-FOR-MEDICAL-NECESS-35198B3141	New policy
Aug 2, 2026	Premera Blue Cross	7.01.160 (effective November 6, 2026) Cartilage Implants forPayerPolicy · PREMERA-7-01-160-EFFECTIVE-NOVEMBER-6-2026-CARTILAGE-IMPLANTS-FOR-3F2223A828	New policy
Aug 2, 2026	Premera Blue Cross	7.01.599 Total Ankle Arthroplasty in AdultsPayerPolicy · PREMERA-7-01-599-TOTAL-ANKLE-ARTHROPLASTY-IN-ADULTS-4A2FB58A2D	New policy
Aug 2, 2026	Premera Blue Cross	7.01.165 Radiofrequency Coblation Tenotomy for MusculoskeletalPayerPolicy · PREMERA-7-01-165-RADIOFREQUENCY-COBLATION-TENOTOMY-FOR-MUSCULOSKELET-E83D9CC29A	New policy
Aug 2, 2026	Premera Blue Cross	5.01.637 Pharmacologic Treatment of AlopeciaPayerPolicy · PREMERA-5-01-637-PHARMACOLOGIC-TREATMENT-OF-ALOPECIA-F4B28EE978	New policy
Aug 2, 2026	Premera Blue Cross	5.01.628 Pharmacologic Treatment of Atopic DermatitisPayerPolicy · PREMERA-5-01-628-PHARMACOLOGIC-TREATMENT-OF-ATOPIC-DERMATITIS-B0B5731FAE	New policy
Aug 2, 2026	Premera Blue Cross	5.01.616 Pharmacologic Treatment of GoutPayerPolicy · PREMERA-5-01-616-PHARMACOLOGIC-TREATMENT-OF-GOUT-10F5CBF73D	New policy
Aug 2, 2026	Premera Blue Cross	5.01.547 Medical Necessity Criteria and Dispensing Quantity LimitsPayerPolicy · PREMERA-5-01-547-MEDICAL-NECESSITY-CRITERIA-AND-DISPENSING-QUANTITY-CF5A898ED9	New policy
Aug 2, 2026	Premera Blue Cross	5.01.532 Cutaneous T-Cell Lymphomas (CTCL): Systemic TherapiesPayerPolicy · PREMERA-5-01-532-CUTANEOUS-T-CELL-LYMPHOMAS-CTCL-SYSTEMIC-THERAPIES-8DB6047865	New policy
Aug 2, 2026	Premera Blue Cross	4.02.06 Uterus Transplantation for Absolute Uterine Factor InfertilityPayerPolicy · PREMERA-4-02-06-UTERUS-TRANSPLANTATION-FOR-ABSOLUTE-UTERINE-FACTOR-I-E87E6E3652	New policy
Aug 2, 2026	Premera Blue Cross	2.02.507 Coronary Angiography for Known or Suspected CoronaryPayerPolicy · PREMERA-2-02-507-CORONARY-ANGIOGRAPHY-FOR-KNOWN-OR-SUSPECTED-CORONAR-7F180EA30C	New policy